back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-01-29 13:31 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+93,436 vol |
133,102 | |
| Filed 2025-01-29 12:43 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+93,436 vol |
133,102 | |
| Filed 2025-01-29 12:43 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+93,436 vol |
||
| Filed 2025-01-29 12:42 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-147,760 vol |
122,584 | |
| Filed 2024-12-20 17:20 Tx date 2024-12-18 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+213,010 vol |
270,344 | |
| Filed 2024-12-20 17:19 Tx date 2024-12-18 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$275,268
+243,600 vol $1.13 each |
889,200 | |
| Filed 2024-12-12 09:57 Tx date 2024-12-09 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+20,700 vol |
39,666 | |
| Filed 2024-12-12 09:56 Tx date 2024-12-09 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-20,700 vol |
57,334 | |
| Filed 2024-12-12 09:55 Tx date 2024-12-11 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-100,000 vol |
645,600 | |
| Filed 2024-11-28 10:18 Tx date 2024-11-27 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+7,966 vol |
18,966 | |
| Filed 2024-11-28 10:17 Tx date 2024-11-27 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-7,966 vol |
78,034 | |
| Filed 2023-12-13 15:03 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+62,100 vol |
86,000 | |
| Filed 2023-12-13 15:02 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$442,547
+231,700 vol $1.91 each |
745,600 | |
| Filed 2023-08-18 11:51 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+23,900 vol |
23,900 | |
| Filed 2023-08-18 11:50 Tx date 2020-08-01 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-18 11:49 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$245,363
+88,900 vol $2.76 each |
513,900 | |
| Filed 2022-12-13 12:26 Tx date 2022-12-09 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$184,800
+80,000 vol $2.31 each |
425,000 | |
| Filed 2022-06-14 17:00 Tx date 2022-06-14 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,429
+11,000 vol $0.86 each |
11,000 | |
| Filed 2022-06-14 16:59 Tx date 2020-08-01 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-13 17:42 Tx date 2021-12-10 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$114,400
+55,000 vol $2.08 each |
345,000 | |
| Filed 2021-03-12 18:13 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$408,000
+120,000 vol $3.40 each |
290,000 | |
| Filed 2020-12-16 17:04 Tx date 2020-12-11 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$317,000
+100,000 vol $3.17 each |
170,000 | |
| Filed 2020-08-05 12:12 Tx date 2020-08-01 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$198,800
+70,000 vol $2.84 each |
70,000 | |
| Filed 2020-08-05 12:08 Tx date 2020-08-01 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|